Cargando…

Negative Symptoms of Psychosis Correlate with Gene Expression of the Wnt/β-Catenin Signaling Pathway in Peripheral Blood

Genes in the Wnt (wingless)/β-catenin signaling pathway have been implicated in schizophrenia pathogenesis. No study has examined this pathway in the broader context of psychosis symptom severity. We investigated the association between symptom severity scores and expression of 25 Wnt pathway genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bousman, Chad A., Glatt, Stephen J., Chandler, Sharon D., Lohr, James, Kremen, William S., Tsuang, Ming T., Everall, Ian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820119/ https://www.ncbi.nlm.nih.gov/pubmed/24236287 http://dx.doi.org/10.1155/2013/852930

Ejemplares similares

Interrogating the Evolutionary Paradox of Schizophrenia: A Novel Framework and Evidence Supporting Recent Negative Selection of Schizophrenia Risk Alleles
por: Liu, Chenxing, et al.
Publicado: (2019)

Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
por: Chana, Gursharan, et al.
Publicado: (2013)

Serotonin transporter polymorphism (5HTTLPR), severe childhood abuse and depressive symptom trajectories in adulthood
por: Nguyen, Timothy B., et al.
Publicado: (2015)

The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates the Effects of Childhood Abuse on Severity of Depressive Symptoms in a Time-Dependent Manner
por: Webb, Caitlin, et al.
Publicado: (2016)

Schizophrenia genetics in the genome-wide era: a review of Japanese studies
por: Kanazawa, Tetsufumi, et al.
Publicado: (2017)

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients
por: Mostaid, Md Shaki, et al.
Publicado: (2017)

T157. FRONTOSTRIATAL CONNECTIVITY IN TREATMENT-RESISTANT SCHIZOPHRENIA: RELATIONSHIP TO POSITIVE SYMPTOMS AND COGNITIVE FLEXIBILITY
por: Cropley, Vanessa, et al.
Publicado: (2018)

O1.6. INCREASED COMPLEMENT FACTORS C3 AND C4 IN SCHIZOPHRENIA AND THE EARLY STAGES OF PSYCHOSIS: IMPLICATIONS FOR CLINICAL SYMPTOMATOLOGY AND CORTICAL THICKNESS
por: Cropley, Vanessa, et al.
Publicado: (2018)

F192. SYSTEMATIC META-ANALYSIS IDENTIFIES FIVE NOVEL ASSOCIATION LOCI FOR SCHIZOPHRENIA
por: Liu, Chenxing, et al.
Publicado: (2018)

Wnt expression is not correlated with β-catenin dysregulation in Dupuytren's Disease
por: O'Gorman, David B, et al.
Publicado: (2006)

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis
por: Bousman, C A, et al.
Publicado: (2013)

RNF152 negatively regulates Wnt/β-catenin signaling in Xenopus embryos
por: Yoon, Gang-Ho, et al.
Publicado: (2022)

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis
por: Devoe, Daniel J., et al.
Publicado: (2023)

Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/β-catenin activity
por: Westfall, Trudi A., et al.
Publicado: (2003)

F63. COGNITIVE CORRELATES OF THE NEGATIVE SYMPTOMS EXPRESSIVE AND EXPERIENTIAL DEFICIT FACTORS IN PSYCHOSIS
por: Sevy, Serge, et al.
Publicado: (2018)

Insights into psychosis risk from leukocyte microRNA expression
por: Jeffries, C D, et al.
Publicado: (2016)

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
por: Ryu, Won-Ji, et al.
Publicado: (2020)

Increased FLYWCH1 Expression is Negatively Correlated with Wnt/β-catenin Target Gene Expression in Acute Myeloid Leukemia Cells
por: Almars, Amany, et al.
Publicado: (2019)

S187. EXPLORING NEURODEVELOPMENTAL AND FAMILIAL ORIGINS OF NEUROLOGICAL SOFT SIGNS IN SCHIZOPHRENIA
por: Cooper, Rebecca, et al.
Publicado: (2020)

WNKs in Wnt/β-catenin signaling
por: Serysheva, Ekatherina, et al.
Publicado: (2014)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

Shifting emphasis from pharmacogenomics to theragnostics
por: Ozdemir, Vural, et al.
Publicado: (2006)

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
por: Lin, Chung-Ming, et al.
Publicado: (2017)

Identifying persistent negative symptoms in first episode psychosis
por: Hovington, Cindy L, et al.
Publicado: (2012)

Protective effect of autophagy in neural ischemia and hypoxia: Negative regulation of the Wnt/β-catenin pathway
por: Shi, Zhen-Yu, et al.
Publicado: (2017)

Nradd Acts as a Negative Feedback Regulator of Wnt/β-Catenin Signaling and Promotes Apoptosis
por: Ozalp, Ozgun, et al.
Publicado: (2021)

Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status
por: Tran, Tanya, et al.
Publicado: (2023)

Wnt2 complements Wnt/β-catenin signaling in colorectal cancer
por: Jung, Youn-Sang, et al.
Publicado: (2015)

Surrogate Wnt agonists that phenocopy canonical Wnt/β-catenin signaling
por: Janda, Claudia Y., et al.
Publicado: (2017)

Running Against the Wnt: How Wnt/β-Catenin Suppresses Adipogenesis
por: de Winter, Twan J. J., et al.
Publicado: (2021)

Delineating gene–environment effects using virtual twins of patients treated with clozapine
por: Mostafa, Sam, et al.
Publicado: (2022)

Wnt/β-catenin signaling in heart regeneration
por: Ozhan, Gunes, et al.
Publicado: (2015)

Wnt/β-catenin signaling and kidney fibrosis
por: Tan, Roderick J, et al.
Publicado: (2014)

Regulation of Wnt/β-catenin signaling by herpesviruses
por: Zwezdaryk, Kevin J, et al.
Publicado: (2016)

Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy
por: Lorenzon, Alessandra, et al.
Publicado: (2017)

Wnt/β-Catenin Signaling in Liver Cancers
por: Wang, Wenhui, et al.
Publicado: (2019)

Wnt/β-Catenin Signaling in Oral Carcinogenesis
por: Reyes, Montserrat, et al.
Publicado: (2020)

Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway
por: Jeong, Woo-Jeong, et al.
Publicado: (2018)

Wnt signaling modulator DKK4 inhibits colorectal cancer metastasis through an AKT/Wnt/β-catenin negative feedback pathway
por: Liang, Junrong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0j952h61bbabdnfd68voptbb6a